Clinical Benefits of Baricitinib Therapy According to Scalp Hair Regrowth in Patients with Severe Alopecia Areata

OBJECTIVES: The present analyses report integrated results from BRAVE-AA1 (NCT03570749) and BRAVE-AA2 (NCT03899259) on the clinical benefits of baricitinib treatment on the basis of the amount of scalp hair regrowth through 52 weeks of treatment. METHODS: This post hoc analysis was conducted with da...

Descripción completa

Detalles Bibliográficos
Autores principales: Senna, Maryanne M., Kwon, Ohsang, Piraccini, Bianca M., Sinclair, Rodney, Ball, Susan, Ding, Yuxin, Chen, Yun-Fei, Dutronc, Yves, King, Brett
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689319/
https://www.ncbi.nlm.nih.gov/pubmed/37991697
http://dx.doi.org/10.1007/s13555-023-01063-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689319/
https://www.ncbi.nlm.nih.gov/pubmed/37991697
http://dx.doi.org/10.1007/s13555-023-01063-2

Ejemplares similares